Micromacinazione company logo
Micromacinazione company logo
Mechanical Milling

Mechanical Milling

Controlled particle size reduction, engineered for consistency and downstream performance.

Mechanical Milling

In the pharmaceutical industry, milling is a fundamental particle engineering technique that serves as the critical bridge between Drug Substance (API) synthesis and Drug Product formulation. While often grouped with micronization, milling specifically refers to the mechanical reduction of coarse solid material into smaller particles, typically achieving a coarser particle size dimension than the sub-10-micron range produced by fluid-jet technology. This physical transformation is essential for optimizing a drug's biopharmaceutical profile and ensuring consistent performance in downstream manufacturing processes


Energy Dynamics and Solid-State Stability


The mechanical milling process involves the transfer of energy to a solid material through rotating parts or grinding media. However, the energy levels involved in these mechanical processes are generally lower than those required for fine micronization via jet milling. As a result, technical issues related to surface amorphization or unwanted polymorphic transitions, which are significant risks in high-energy jet milling, are typically far less pronounced in mechanical milling applications. Because the material is not pushed to the high-energy metastable states characteristic of micronization, the primary crystalline structure of the API is more readily preserved.


Technical Challenges


While amorphization is less of a concern, mechanical milling introduces distinct technical challenges that require rigorous process control:


  • Thermal Management and Overheating: Unlike jet milling, which benefits from the Joule–Thomson effect (adiabatic cooling as gas expands), mechanical mills generate heat through high-speed friction and impact. This poses a significant risk for thermolabile compounds, where even moderate temperature increases can lead to chemical degradation or melting of the API.
  • Heavy Metal Contamination: A critical risk in mechanical milling is the potential for product contamination generated by the equipment’s mechanical moving parts. The constant stress and wear on components such as pins, blades, or grinding media (often constructed from steel or zirconium) can introduce trace heavy metals into the Drug Substance. High-purity applications must, therefore, utilize advanced metallurgy or specialized coatings to mitigate this risk.

Customers

  • Small biotechs to Big Pharma
  • CDMO’s (API, Dosage Form, Integrated)
  • Functional Excipient Companies

Phases of Development Supported:

  • Lifecycle Presence: From Pre-Clinical to Commercial Phase
  • Fully Equipped from few grams up to metric Ton Batches
  • One Independent R&D Lab and 3 fully inspected GMP Buildings

Types of Molecules

  • Small Molecule APIs and HPAPIs
  • Functional Excipients
  • NCEs, 505b2s, Generics
Milling

Mechanical Milling Technologies

Selecting the appropriate milling technology depends on the physical characteristics of the API and the target particle size distribution.


In the following sections, we will explore the technical specifics of our mechanical milling platforms, focusing on the mechanisms and applications:

Pin Mill +

Pin mills are high-speed mechanical impact systems designed for fine to intermediate grinding of brittle drug substances. Comminution occurs through intensive shear and impact forces as material passes between sets of pins mounted on rapidly rotating disks. Unlike fluid-jet technology, this mechanical process generates heat through friction, requiring careful thermal management for thermolabile APIs. Process optimization relies on the control of critical operating parameters, such as powder feed rate and rotor speed. By precisely adjusting these variables, it is possible to achieve the required particle size distribution and ensure material homogeneity, facilitating consistent performance in downstream pharmaceutical formulation.

Conical Mill +

Conical mills are low-energy mechanical systems engineered for uniform size reduction and the efficient de-lumping of agglomerated pharmaceutical powders. This technology utilizes a rotating impeller to push the active ingredient through a conical screen, facilitating size reduction with minimal shear. Because it operates at lower speeds compared to impact mills, it significantly reduces the risk of overheating, making it suitable for heat-sensitive materials. While providing a coarser particle size than jet milling, it effectively enhances bulk properties and flowability. This makes conical milling a vital step for ensuring consistent blending and performance in downstream tableting or encapsulation.

Centrifugal Impact Mill +

Centrifugal Impact Mills (CIM) utilize high centrifugal forces to accelerate API particles against specialized impact surfaces or stationary pins to achieve size reduction. Similar to the classification mechanism used in opposed jet mills, the CIM incorporates a rotating basket that functions as a dynamic classifier. This basket provides superior control over the particle size cut-off by returning larger material to the grinding track while allowing target-sized particles to pass. This configuration is optimized for high-throughput applications requiring both mechanical robustness and consistent material homogeneity. Process optimization and control over the final particle size distribution are achieved by precisely adjusting critical operating parameters: the powder feed rate, the beater rotation speed, and classifier speed.

Milling Explained

Milling Explained

Milling is a way to shrink medicine into smaller grains using machines with moving parts, like spinning blades or screens. Imagine a high-tech version of a kitchen grinder. While it doesn't make the particles as tiny as micronization, it creates uniform pieces that are perfect for making tablets or capsules. This ensures every pill is consistent and works correctly. Because the machine parts move quickly, they can generate heat, so we must be careful with medicines that might melt. It is a reliable step to make sure your medicine is high-quality.

Just Say MicMac.
We'll Take It From There.

Whether you are at the start of your development journey or scaling to commercial supply, we are ready to work with you. Let's talk about your molecule.

Newsletter

Science and Insights.
Direct to You.